Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Analyst Ratings

• Total Analysts: 5
• Consensus Rating: Buy
• Price Target: $25.60
• Upside: +56.77%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $41 → $40	Strong Buy	Maintains	$41 → $40	+144.95%	Aug 22, 2025
Kelsey Goodwin Piper Sandler	Piper Sandler	Buy Initiates $36	Buy	Initiates	$36	+120.45%	Aug 19, 2025
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Sell → Hold Upgrades $8	Sell → Hold	Upgrades	$8	-51.01%	May 23, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $44 → $41	Strong Buy	Maintains	$44 → $41	+151.07%	May 16, 2025
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Sell Initiates $8	Sell	Initiates	$8	-51.01%	Apr 17, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $45 → $44	Strong Buy	Maintains	$45 → $44	+169.44%	Apr 7, 2025
Eric Schmidt Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $13	Buy	Reiterates	$13	-20.33%	Mar 13, 2025
David Nierengarten Wedbush	Wedbush	Buy Reiterates $31	Buy	Reiterates	$31	+89.83%	Feb 12, 2025
David Nierengarten Wedbush	Wedbush	Buy Initiates $31	Buy	Initiates	$31	+89.83%	Feb 6, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $42 → $45	Strong Buy	Maintains	$42 → $45	+175.57%	Jan 27, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $42	Strong Buy	Initiates	$42	+157.20%	Dec 6, 2024
Eric Schmidt Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Oct 8, 2024
Stephen Willey Stifel	Stifel	Strong Buy Initiates $47	Strong Buy	Initiates	$47	+187.81%	Oct 8, 2024
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $35	Buy	Initiates	$35	+114.33%	Oct 8, 2024
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Oct 8, 2024